Concepedia

Sarah Wilmore

SW

Statistics

Publications

4

Citations

151

H-Index

4

Active since

2016

Affiliations

University of Southampton(Current)

University Hospital Southampton NHS Foundation Trust

Cancer Research UK

Sarah Wilmore is an author at University of Southampton specializing in cancer research, cell signaling, and tumor biology.

Top concepts

Publications per year

2016–2021

4

Publications

4

The Dual Syk/JAK Inhibitor Cerdulatinib Antagonizes B-cell Receptor and Microenvironmental Signaling in Chronic Lymphocytic Leukemia

Matthew D. Blunt, Stefan Koehrer, Rachel Dobson et al. · Clinical Cancer Research · 2016 · 64 citations · Full text

Target-Based Screening against eIF4A1 Reveals the Marine Natural Product Elatol as a Novel Inhibitor of Translation Initiation with <i>In Vivo</i> Antitumor Activity

Tara L. Peters, Joseph Tillotson, Alison Yeomans et al. · Clinical Cancer Research · 2018 · 43 citations · Full text

Targeted inhibition of eIF4A suppresses B-cell receptor-induced translation and expression of MYC and MCL1 in chronic lymphocytic leukemia cells

Sarah Wilmore, Karly‐Rai Rogers‐Broadway, Joe Taylor et al. · Cellular and Molecular Life Sciences · 2021 · 34 citations · Full text

PEITC-mediated inhibition of mRNA translation is associated with both inhibition of mTORC1 and increased eIF2α phosphorylation in established cell lines and primary human leukemia cells

Alison Yeomans, Elizabeth Lemm, Sarah Wilmore et al. · Oncotarget · 2016 · 10 citations · Full text

, , +16

1–4 of 4